Toriihara A - Search Results

1

¹⁸F-FDG PET/CT for monitoring anti-PD-1 therapy in patients with non-small cell lung cancer using SUV harmonization of results obtained with various types of PET/CT scanners used at different centers.

Ito K, Kitajima K, Toriihara A, Ishibashi M, Nakahara T, Daisaki H, Ohe Y, Honda R, Kijima T, Hasegawa S, Nakajo M. Ito K, et al. Among authors: toriihara a. Ann Nucl Med. 2021 Nov;35(11):1253-1263. doi: 10.1007/s12149-021-01667-8. Epub 2021 Aug 9. Ann Nucl Med. 2021. PMID: 34370219

2

F-18 FDG PET/CT of polymyalgia rheumatica.

Toriihara A, Seto Y, Yoshida K, Umehara I, Nakagawa T, Liu R, Iwamoto I. Toriihara A, et al. Clin Nucl Med. 2009 May;34(5):305-6. doi: 10.1097/RLU.0b013e31819e51fd. Clin Nucl Med. 2009. PMID: 19387211 No abstract available.

3

Normal variants of bowel FDG uptake in dual-time-point PET/CT imaging.

Toriihara A, Yoshida K, Umehara I, Shibuya H. Toriihara A, et al. Ann Nucl Med. 2011 Apr;25(3):173-8. doi: 10.1007/s12149-010-0439-x. Epub 2010 Nov 19. Ann Nucl Med. 2011. PMID: 21088936

4

Utility of F-18 FDG PET/CT in screening for paraneoplastic neurological syndromes.

Matsuhisa A, Toriihara A, Kubota K, Makino T, Mizusawa H, Shibuya H. Matsuhisa A, et al. Among authors: toriihara a. Clin Nucl Med. 2012 Jan;37(1):39-43. doi: 10.1097/RLU.0b013e3182393390. Clin Nucl Med. 2012. PMID: 22157026

5

Evaluation of sequential FDG-PET/CT for monitoring bone metastasis of breast cancer during therapy: correlation between morphological and metabolic changes with tumor markers.

Katayama T, Kubota K, Machida Y, Toriihara A, Shibuya H. Katayama T, et al. Among authors: toriihara a. Ann Nucl Med. 2012 Jun;26(5):426-35. doi: 10.1007/s12149-012-0595-2. Epub 2012 Apr 3. Ann Nucl Med. 2012. PMID: 22477261

6

Optimal timing of post-treatment [18F]fluorodeoxyglucose-PET/CT for patients with head and neck malignancy.

Nakamura S, Toriihara A, Okochi K, Watanabe H, Shibuya H, Kurabayashi T. Nakamura S, et al. Among authors: toriihara a. Nucl Med Commun. 2013 Feb;34(2):162-7. doi: 10.1097/MNM.0b013e32835bdfe3. Nucl Med Commun. 2013. PMID: 23196675

7

Eligibility for bevacizumab as an independent prognostic factor for patients with advanced non-squamous non-small cell lung cancer: a retrospective cohort study.

Takagi Y, Toriihara A, Nakahara Y, Yomota M, Okuma Y, Hosomi Y, Shibuya M, Okamura T. Takagi Y, et al. Among authors: toriihara a. PLoS One. 2013;8(3):e59700. doi: 10.1371/journal.pone.0059700. Epub 2013 Mar 26. PLoS One. 2013. PMID: 23555751 Free PMC article.

8

Long-term follow-up using 18F-FDG PET/CT for postoperative olfactory neuroblastoma.

Fujioka T, Toriihara A, Kubota K, Machida Y, Nakamura S, Kishimoto S, Ohashi I, Shibuya H. Fujioka T, et al. Among authors: toriihara a. Nucl Med Commun. 2014 Aug;35(8):857-63. doi: 10.1097/MNM.0000000000000135. Nucl Med Commun. 2014. PMID: 24751700

9

Comparison of FDG-PET/CT images between chronic renal failure patients on hemodialysis and controls.

Toriihara A, Kitazume Y, Nishida H, Kubota K, Nakadate M, Tateishi U. Toriihara A, et al. Am J Nucl Med Mol Imaging. 2015 Jan 15;5(2):204-11. eCollection 2015. Am J Nucl Med Mol Imaging. 2015. PMID: 25973341 Free PMC article.

10

Dual-time-point FDG-PET/CT Imaging of Temporal Bone Chondroblastoma: A Report of Two Cases.

Toriihara A, Tsunoda A, Takemoto A, Kubota K, Machida Y, Tateishi U. Toriihara A, et al. Asia Ocean J Nucl Med Biol. 2015 Summer;3(2):120-4. Asia Ocean J Nucl Med Biol. 2015. PMID: 27408892 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters